Longitudinal assessment of plasma EBV-DNA in non-endemic EBV-related nasopharyngeal cancer (NPC): the LEA study

鼻咽癌 鼻咽癌 医学 病毒学 肿瘤科 免疫学 内科学 放射治疗
作者
Salvatore Alfieri,Rebecca Romanò,Sara Renata Francesca Marceglia,Carolina Sciortino,W. Ferrari Bravo,Monica Zucchini,Maria Luigia Piscitelli,Imperia Nuzzolese,Stefano Cavalieri,Cristiana Bergamini,Elena Virginia Colombo,Arianna Ottini,Loris De Cecco,Deborah Lenoci,Nicola Alessandro Iacovelli,Marco Guzzo,Ester M. Orlandi,Laura D. Locati,Paolo Bossi,Lisa Francesca Licitra
出处
期刊:European Journal of Cancer [Elsevier BV]
卷期号:226: 115625-115625 被引量:10
标识
DOI:10.1016/j.ejca.2025.115625
摘要

BACKGROUND: Plasma Epstein Barr Virus (EBV)-DNA is an established biomarker for endemic EBV-related nasopharyngeal carcinoma (NPC). Its relevance in non-endemic regions is less understood. This study longitudinally assessed plasma EBV-DNA (LEA study) throughout the curative management of non-endemic EBV-related NPC to evaluate its prognostic value. MATERIALS AND METHODS: Between 2012 and 2023, patients with non-endemic, non-metastatic, histologically confirmed EBER+ NPC treated at a tertiary center were retrospectively analyzed. Plasma EBV-DNA levels were measured at pre-treatment (T1), early (T2a, ≤6 weeks) and late (T2b, ≤14 weeks) post-treatment, during follow-up (T3), and after induction chemotherapy (T4), when applicable. EBV-DNA was analyzed for its association with recurrence-free survival (RFS). RESULTS: At a median follow-up of 60 months (range: 9-134), 167 patients were included. Median age was 50 years (range: 22-75), with 72 % male; 84 % had stage III-IV disease (TNM VIII Edition). Pre-treatment EBV-DNA was detected in 96 % of patients, with no predictive cut-off (median RFS: 43 vs. 62 months for detectable vs. undetectable EBV-DNA). Post-treatment undetectable EBV-DNA correlated with better RFS, also with no cut-off. Follow-up EBV-DNA anticipated recurrence in 71 % of cases by a median of 38 days (range: 11-365). Persistently negative follow-up EBV-DNA was observed in 91 % of non-recurrent patients; isolated positive spikes lacked prognostic significance. Post-induction chemotherapy EBV-DNA demonstrated a 92 % negative predictive value for recurrence. CONCLUSIONS: Plasma EBV-DNA is a valuable prognostic biomarker for non-endemic NPC. Pre- and post-treatment undetectable EBV-DNA holds a positive prognostic value. Post-induction EBV-DNA is the most informative timepoint. Longitudinal EBV-DNA monitoring is warranted in clinical practice.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
sunziyi发布了新的文献求助10
2秒前
2秒前
小马甲的应助被zdenglong采纳,获得10
3秒前
Monster完成签到,获得积分20
3秒前
3秒前
山北大花萼完成签到,获得积分10
4秒前
乐乐的应助被小饭采纳,获得10
4秒前
zch完成签到,获得积分10
5秒前
5秒前
秋风的应助被吱吱采纳,获得10
5秒前
6秒前
七七发布了新的文献求助10
6秒前
小董完成签到,获得积分20
6秒前
单薄冰安发布了新的文献求助10
6秒前
精明的如音完成签到,获得积分10
7秒前
酷波er的应助被楠楠采纳,获得10
7秒前
wanci的应助被echo采纳,获得10
7秒前
FOX发布了新的文献求助10
8秒前
8秒前
爆米花的应助被何文鑫采纳,获得10
8秒前
大模型的应助被wangfei采纳,获得10
8秒前
carpediem完成签到,获得积分10
8秒前
ZZt完成签到,获得积分10
8秒前
9秒前
chai发布了新的文献求助10
10秒前
worakls完成签到,获得积分10
10秒前
wg发布了新的文献求助10
10秒前
10秒前
门牙关注了科研通微信公众号
10秒前
慕青的应助被carpediem采纳,获得10
11秒前
12秒前
SCL987654321发布了新的文献求助10
12秒前
万能图书馆的应助被艾格采纳,获得10
12秒前
大模型的应助被sci采纳,获得30
14秒前
朴素香氛发布了新的文献求助10
14秒前
正直的惜文完成签到,获得积分20
14秒前
15秒前
sunziyi完成签到,获得积分20
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188177
求助须知:如何正确求助?哪些是违规求助? 9575987
关于积分的说明 21844723
捐赠科研通 7785975
什么是DOI,文献DOI怎么找? 3435220
关于科研通互助平台的介绍 2559558
邀请新用户注册赠送积分活动 2482095